CGEN FY 2023 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$202M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$33M+346.1% YoY

Gross Profit

$31M94.0% margin

Operating Income

-$13M-38.8% margin

Net Income

-$19M-56.1% margin

EPS (Diluted)

$-0.21

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$36M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$121M

Total Liabilities

$56M

Stockholders' Equity

$66M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$8M	+346.1%
Gross Profit	$31M	$7M	+382.1%
Operating Income	-$13M	-$35M	+63.3%
Net Income	-$19M	-$34M	+44.3%